Concepts (176)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Texas | 8 | 2021 | 1237 | 1.04 | Why? |
| Thiepins | 1 | 2020 | 10 | 0.87 | Why? |
| Construction Industry | 1 | 2020 | 51 | 0.82 | Why? |
| Postal Service | 1 | 2020 | 88 | 0.81 | Why? |
| Patient Isolators | 1 | 2021 | 201 | 0.78 | Why? |
| Strepsirhini | 1 | 2017 | 4 | 0.74 | Why? |
| Oxazines | 1 | 2020 | 279 | 0.73 | Why? |
| Triazines | 1 | 2020 | 246 | 0.70 | Why? |
| Fetal Mortality | 1 | 2017 | 34 | 0.68 | Why? |
| Influenza, Human | 6 | 2020 | 10779 | 0.66 | Why? |
| Live Birth | 1 | 2017 | 200 | 0.61 | Why? |
| Pharmacies | 1 | 2021 | 356 | 0.61 | Why? |
| Birth Rate | 1 | 2017 | 137 | 0.60 | Why? |
| Surge Capacity | 2 | 2020 | 894 | 0.60 | Why? |
| Hospital Bed Capacity | 2 | 2020 | 1300 | 0.59 | Why? |
| Polyploidy | 1 | 2014 | 16 | 0.58 | Why? |
| Magnoliopsida | 1 | 2014 | 36 | 0.57 | Why? |
| Health Services | 2 | 2020 | 765 | 0.56 | Why? |
| Forecasting | 5 | 2021 | 4492 | 0.55 | Why? |
| Pyridines | 1 | 2020 | 680 | 0.54 | Why? |
| Transportation | 1 | 2020 | 691 | 0.53 | Why? |
| Social Behavior | 2 | 2021 | 882 | 0.50 | Why? |
| HIV Antibodies | 1 | 2018 | 776 | 0.46 | Why? |
| Orthomyxoviridae | 1 | 2020 | 1168 | 0.45 | Why? |
| Abortion, Spontaneous | 1 | 2017 | 776 | 0.44 | Why? |
| Search Engine | 1 | 2018 | 628 | 0.43 | Why? |
| Abortion, Induced | 1 | 2017 | 437 | 0.42 | Why? |
| Biological Evolution | 2 | 2021 | 641 | 0.40 | Why? |
| Data Collection | 1 | 2018 | 1769 | 0.37 | Why? |
| Sexual Behavior | 1 | 2018 | 1322 | 0.37 | Why? |
| Ventilators, Mechanical | 2 | 2020 | 2193 | 0.36 | Why? |
| Public Health Surveillance | 2 | 2020 | 3129 | 0.36 | Why? |
| Family Characteristics | 1 | 2018 | 2551 | 0.33 | Why? |
| Stochastic Processes | 3 | 2020 | 369 | 0.32 | Why? |
| Models, Statistical | 3 | 2020 | 5312 | 0.32 | Why? |
| Seasons | 5 | 2020 | 4071 | 0.31 | Why? |
| Disease Transmission, Infectious | 2 | 2020 | 9044 | 0.30 | Why? |
| Logistic Models | 1 | 2020 | 9089 | 0.29 | Why? |
| Epidemics | 3 | 2020 | 6407 | 0.29 | Why? |
| Gastrointestinal Microbiome | 1 | 2017 | 1961 | 0.27 | Why? |
| Hospitalization | 6 | 2021 | 54280 | 0.27 | Why? |
| Zika Virus Infection | 2 | 2018 | 1920 | 0.27 | Why? |
| Models, Theoretical | 8 | 2021 | 6659 | 0.26 | Why? |
| Health Policy | 3 | 2020 | 6242 | 0.26 | Why? |
| Cities | 3 | 2020 | 4937 | 0.26 | Why? |
| Influenza Vaccines | 2 | 2017 | 2941 | 0.26 | Why? |
| Influenza A Virus, H1N1 Subtype | 1 | 2017 | 2984 | 0.24 | Why? |
| Public Health | 6 | 2021 | 16359 | 0.24 | Why? |
| Occupational Exposure | 1 | 2020 | 4742 | 0.23 | Why? |
| United States | 10 | 2021 | 46150 | 0.22 | Why? |
| Dibenzothiepins | 1 | 2020 | 39 | 0.21 | Why? |
| Cost-Benefit Analysis | 3 | 2021 | 2259 | 0.21 | Why? |
| Pandemics | 13 | 2020 | 389249 | 0.21 | Why? |
| Computer Simulation | 3 | 2021 | 4982 | 0.21 | Why? |
| Disease Outbreaks | 6 | 2021 | 27595 | 0.21 | Why? |
| Models, Biological | 1 | 2017 | 4907 | 0.20 | Why? |
| Health Services Accessibility | 2 | 2021 | 10697 | 0.20 | Why? |
| Pneumonia, Viral | 10 | 2020 | 243684 | 0.20 | Why? |
| Coronavirus Infections | 10 | 2020 | 253789 | 0.19 | Why? |
| Quarantine | 3 | 2021 | 18418 | 0.19 | Why? |
| Grooming | 1 | 2017 | 1 | 0.19 | Why? |
| Risk Assessment | 2 | 2020 | 25439 | 0.18 | Why? |
| Morpholines | 1 | 2020 | 351 | 0.18 | Why? |
| HIV Infections | 3 | 2018 | 11620 | 0.17 | Why? |
| Time | 1 | 2020 | 631 | 0.17 | Why? |
| Madagascar | 1 | 2017 | 197 | 0.17 | Why? |
| Humans | 34 | 2021 | 930598 | 0.16 | Why? |
| Social Media | 1 | 2018 | 5798 | 0.16 | Why? |
| Oseltamivir | 1 | 2020 | 583 | 0.15 | Why? |
| Massachusetts | 1 | 2021 | 1279 | 0.15 | Why? |
| Respiratory Insufficiency | 1 | 2017 | 7301 | 0.15 | Why? |
| Mass Vaccination | 3 | 2017 | 1101 | 0.15 | Why? |
| Diploidy | 1 | 2014 | 6 | 0.15 | Why? |
| Genetic Speciation | 1 | 2014 | 13 | 0.15 | Why? |
| Schools | 2 | 2021 | 4187 | 0.14 | Why? |
| Epidemiological Monitoring | 2 | 2018 | 3493 | 0.14 | Why? |
| Pyridones | 1 | 2020 | 738 | 0.14 | Why? |
| RNA, Ribosomal, 16S | 1 | 2017 | 793 | 0.14 | Why? |
| Time Factors | 5 | 2020 | 31397 | 0.13 | Why? |
| Adolescent | 8 | 2021 | 86841 | 0.13 | Why? |
| Africa South of the Sahara | 1 | 2018 | 1335 | 0.13 | Why? |
| Dengue | 2 | 2017 | 1565 | 0.12 | Why? |
| Cell Proliferation | 1 | 2020 | 1973 | 0.12 | Why? |
| Safety | 1 | 2020 | 1583 | 0.12 | Why? |
| Infant | 3 | 2020 | 30274 | 0.12 | Why? |
| Models, Genetic | 1 | 2014 | 434 | 0.12 | Why? |
| Homosexuality, Male | 2 | 2018 | 1158 | 0.12 | Why? |
| Risk | 3 | 2021 | 5288 | 0.12 | Why? |
| Linear Models | 1 | 2018 | 1914 | 0.11 | Why? |
| Child, Preschool | 4 | 2020 | 36283 | 0.11 | Why? |
| Dengue Vaccines | 1 | 2013 | 123 | 0.11 | Why? |
| Drug Resistance, Viral | 1 | 2017 | 1083 | 0.10 | Why? |
| Patient Isolation | 2 | 2021 | 3182 | 0.10 | Why? |
| HIV | 1 | 2017 | 1116 | 0.10 | Why? |
| China | 4 | 2020 | 50654 | 0.10 | Why? |
| Homeless Persons | 1 | 2021 | 1171 | 0.10 | Why? |
| Minority Groups | 1 | 2020 | 1631 | 0.10 | Why? |
| Residence Characteristics | 1 | 2020 | 1927 | 0.10 | Why? |
| Intensive Care Units | 3 | 2021 | 29594 | 0.10 | Why? |
| Cost of Illness | 1 | 2020 | 1903 | 0.10 | Why? |
| Vaccination | 4 | 2021 | 19050 | 0.10 | Why? |
| Betacoronavirus | 8 | 2020 | 204454 | 0.10 | Why? |
| Young Adult | 5 | 2020 | 93724 | 0.10 | Why? |
| Child | 6 | 2021 | 70012 | 0.09 | Why? |
| Pre-Exposure Prophylaxis | 1 | 2018 | 1138 | 0.09 | Why? |
| Mexico | 1 | 2017 | 2787 | 0.09 | Why? |
| Anti-Retroviral Agents | 1 | 2017 | 1099 | 0.09 | Why? |
| Basic Reproduction Number | 1 | 2020 | 2676 | 0.09 | Why? |
| Rural Population | 1 | 2020 | 2408 | 0.09 | Why? |
| Publishing | 1 | 2018 | 990 | 0.09 | Why? |
| Workplace | 1 | 2020 | 2075 | 0.09 | Why? |
| Communicable Diseases | 2 | 2021 | 2148 | 0.08 | Why? |
| Antiviral Agents | 1 | 2020 | 41703 | 0.08 | Why? |
| RNA, Messenger | 1 | 2020 | 5131 | 0.08 | Why? |
| Vulnerable Populations | 1 | 2020 | 3099 | 0.08 | Why? |
| Anti-HIV Agents | 1 | 2018 | 2209 | 0.07 | Why? |
| San Francisco | 2 | 2018 | 711 | 0.07 | Why? |
| Civil Defense | 1 | 2017 | 1687 | 0.07 | Why? |
| Electronic Health Records | 1 | 2018 | 3492 | 0.07 | Why? |
| Adult | 6 | 2020 | 244371 | 0.07 | Why? |
| Pregnancy | 2 | 2017 | 23879 | 0.07 | Why? |
| Middle Aged | 5 | 2020 | 270681 | 0.07 | Why? |
| Pregnant Women | 1 | 2017 | 2535 | 0.06 | Why? |
| Internet | 2 | 2018 | 6204 | 0.06 | Why? |
| Databases, Factual | 1 | 2018 | 6248 | 0.06 | Why? |
| Contact Tracing | 2 | 2021 | 8448 | 0.06 | Why? |
| Computational Biology | 1 | 2017 | 4514 | 0.06 | Why? |
| Seroepidemiologic Studies | 1 | 2018 | 10017 | 0.06 | Why? |
| Machine Learning | 1 | 2018 | 4395 | 0.06 | Why? |
| Reproducibility of Results | 1 | 2018 | 11304 | 0.06 | Why? |
| Algorithms | 1 | 2018 | 7346 | 0.05 | Why? |
| Travel | 1 | 2020 | 7220 | 0.05 | Why? |
| Risk Factors | 2 | 2020 | 71621 | 0.05 | Why? |
| Patient Acceptance of Health Care | 1 | 2020 | 5002 | 0.05 | Why? |
| Communicable Disease Control | 2 | 2021 | 29620 | 0.05 | Why? |
| United Kingdom | 1 | 2021 | 18046 | 0.05 | Why? |
| Host-Pathogen Interactions | 1 | 2021 | 11041 | 0.05 | Why? |
| Hospitals | 1 | 2020 | 11793 | 0.05 | Why? |
| Population Surveillance | 1 | 2017 | 4967 | 0.05 | Why? |
| Viral Load | 1 | 2020 | 15850 | 0.05 | Why? |
| Infant, Newborn | 1 | 2020 | 23105 | 0.05 | Why? |
| Virus Replication | 1 | 2020 | 14331 | 0.05 | Why? |
| Female | 5 | 2020 | 380317 | 0.04 | Why? |
| Biomedical Research | 1 | 2018 | 5270 | 0.04 | Why? |
| Likelihood Functions | 1 | 2020 | 719 | 0.04 | Why? |
| Puerto Rico | 1 | 2017 | 177 | 0.04 | Why? |
| Male | 6 | 2020 | 367725 | 0.04 | Why? |
| Peer Review | 1 | 2018 | 204 | 0.04 | Why? |
| Comorbidity | 1 | 2020 | 34796 | 0.04 | Why? |
| Animals | 4 | 2021 | 78931 | 0.04 | Why? |
| Drug Resistance | 1 | 2018 | 395 | 0.04 | Why? |
| Delivery of Health Care | 1 | 2021 | 15909 | 0.03 | Why? |
| Privacy | 1 | 2020 | 636 | 0.03 | Why? |
| Spatio-Temporal Analysis | 1 | 2020 | 1182 | 0.03 | Why? |
| Surveys and Questionnaires | 1 | 2021 | 43792 | 0.03 | Why? |
| Incidence | 3 | 2020 | 25622 | 0.03 | Why? |
| Secondary Prevention | 1 | 2017 | 762 | 0.03 | Why? |
| Life Expectancy | 1 | 2017 | 474 | 0.03 | Why? |
| Public Health Practice | 1 | 2020 | 945 | 0.03 | Why? |
| Models, Economic | 1 | 2013 | 316 | 0.03 | Why? |
| Mathematical Concepts | 1 | 2011 | 370 | 0.02 | Why? |
| Guidelines as Topic | 1 | 2021 | 2844 | 0.02 | Why? |
| Guideline Adherence | 1 | 2021 | 2309 | 0.02 | Why? |
| Internationality | 1 | 2020 | 3297 | 0.02 | Why? |
| Hemorrhagic Fever, Ebola | 1 | 2018 | 1475 | 0.02 | Why? |
| Models, Immunological | 1 | 2011 | 727 | 0.02 | Why? |
| Aged | 2 | 2020 | 215776 | 0.02 | Why? |
| Immunity, Herd | 1 | 2013 | 1011 | 0.02 | Why? |
| Communicable Diseases, Emerging | 1 | 2018 | 2523 | 0.02 | Why? |
| Uncertainty | 1 | 2013 | 1888 | 0.01 | Why? |
| Immunization Programs | 1 | 2013 | 2006 | 0.01 | Why? |
| Mass Screening | 1 | 2020 | 8005 | 0.01 | Why? |
| Global Health | 1 | 2020 | 13911 | 0.01 | Why? |
| Brazil | 1 | 2013 | 12582 | 0.01 | Why? |
| Practice Guidelines as Topic | 1 | 2013 | 15421 | 0.01 | Why? |
| Infection Control | 1 | 2011 | 23131 | 0.00 | Why? |
Meyers's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(176)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(96)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_